Searching for wheat plants with low toxicity in celiac disease: Between direct toxicity and immunologic activation

Digestive and Liver Disease

Volumn 43, Issue 1, 2011, Pages 34-39

  Carroccio, Antonio ^a   Di Prima, Lidia ^a   Noto, Davide ^a   Fayer, Francesca ^a   Ambrosiano, Giuseppe ^a   Villanacci, Vincenzo ^b   Lammers, Karen ^c   Lafiandra, Domenico ^d   De Ambrogio, Enzo ^e   Di Fede, Gaetana ^a   Iacono, Giuseppe ^f   Pogna, Norberto ^g  

^a UNIVERSITY OF PALERMO   (Italy)

^b II Servizio di Anatomia ed Istologia Patologica Spedali Civili Brescia   (Italy)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TUSCIA   (Italy)

^e SocietL Produttori Sementi Bologna PSB   (Italy)

^f Di Cristina Hospital   (Italy)

^g CRA QCE   (Italy)

Author keywords

Anti transglutaminase antibodies; Celiac disease; Cytokines; Histology; In vitro culture; Wheat species

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GLIADIN; GLUTENIN; IMMUNOGLOBULIN A; INTERLEUKIN 10; INTERLEUKIN 2; PROLAMIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; DUODENUM MUCOSA; HUMAN; HUMAN TISSUE; IMMUNOASSAY; IMMUNOHISTOCHEMISTRY; INNATE IMMUNITY; INTESTINE CELL; ORGAN CULTURE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; T LYMPHOCYTE; WHEAT; WILD TYPE;

ANTIBODIES; CELIAC DISEASE; GENE DELETION; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-10; INTERLEUKIN-2; INTESTINAL MUCOSA; PROLAMINS; TISSUE CULTURE TECHNIQUES; TRITICUM;

EID: 78649929787     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2010.05.005     Document Type: Article

References (50)

1. Bingley P.J., Williams A.J., Norcross A.J., et al. Undiagnosed coeliac disease at age seven: population based prospective birth cohort study. Br Med J 2004, 328:322-323.
2. Mäki M., Mustalahti K., Kokkonen J., et al. Prevalence of celiac disease among children in Finland. N Engl J Med 2003, 348:2517-2524.
3. Not T., Horwath K., Hill I.D., et al. Celiac disease risk in the USA: high prevalence of anti-endomysium antibodies in healthy blood donors. Scand J Gastroenterol 1998, 33:494-498.
4. Kolho K.L., Farkkila M.A., Savilahti E. Undiagnosed celiac disease is common in Finnish adults. Scand J Gastroenterol 1998, 33:1280-1283.
5. Catassi C., Ratsch I.M., Fabiani E., et al. Coeliac disease in the year 2000: exploring the iceberg. Lancet 1994, 343:200-203.
6. Arentz-Hansen E.H., McAdam S., Molberg O., et al. Celiac lesion T cells recognize epitopes that cluster in regions of gliadins rich in proline residues. Gastroenterology 2002, 123:803-809.
7. Arentz-Hansen E.H., Körner R., Molberg O., et al. The intestinal T-cell response to α-gliadin in adult celiac disease is focused on a single deamidated glutamine targeted by tissue transglutaminase. J Exp Med 2000, 191:603-612.
8. Vader L.W., Stepniak D.T., Bunnik E.M., et al. Characterization of cereal toxicity for celiac disease patients based on protein homology in grains. Gastroenterology 2003, 125:1105-1113.
9. Sollid L.M. Coeliac disease: dissecting a complex inflammatory disorder. Nat Rev Immunol 2002, 2:647-655.
10. Corrao G., Corazza G.R., Bagnardi V., et al. Mortality in patients with coeliac disease and their relatives: a cohort study. Lancet 2001, 358:356-361.
11. Branski D., Fasano A., Troncone R. Latest developments in the pathogenesis and treatment of celiac disease. J Pediatr 2006, 149:295-300.
12. Di Cagno R., De Angelis M., Auricchio S., et al. Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients. Appl Envison Microbiol 2004, 70:1088-1096.
13. Choi K., Siegel M., Piper J.L., et al. Chemistry and biology of dihydroisoxazole derivatives: selective inhibitors of human transglutaminase 2. Chem Biol 2005, 4:469-475.
14. Paterson B.M., Lammers K.M., Arrieta M.C., et al. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in celiac disease subjects: a proof of concept study. Aliment Pharmacol Ther 2007, 26:757-766.
15. Carroccio A., Ambrosiano G., Di Prima L., et al. Clinical symptoms in celiac patients on gluten-free diet. Scand J Gastroenterol 2008, 43:1315-1321.
16. Lafiandra D., Splendido R., Tomassini C., et al. Lack of expression of certain storage proteins in bread wheats; distribution and genetic analysis of null forms. Proceedings 3rd international workshop on gluten proteins 1987, 71-90. World Scientific Publishing, Singapore. R. Laszity, F. Bekes (Eds.).
17. Frisoni M., Corazza G.R., Lafiandra D., et al. Wheat deficient in gliadins: promising tool for treatment of coeliac disease. Gut 1995, 36:375-378.
18. De Ritis G., Occorsio P., Auricchio S., et al. Toxicity of wheat flour and protein-derived peptides for in vitro developing intestine from rat fetus. Pediatric Res 1979, 13:1255-1261.
19. Fais S., Maiuri L., Pallone F., et al. Gliadin-induced changes in the expression of MHC-class II antigens by human small intestinal epithelium. Organ culture studies celiac disease mucosa. Gut 1992, 33:472-475.
20. Marsh M.N. Gluten, major histocompatibility complex and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (celiac sprue). Gastroenterology 1992, 102:330-354.
21. Oberhuber G., Granditsch G., Vogelsang H. The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 1999, 11:1185-1194.
22. Corazza G.R., Villanacci V. Coeliac disease, some considerations on the histological diagnosis. J Clin Pathol 2005, 58:573-574.
23. Corazza G.R., Villanacci V., Zambelli C., et al. Comparison of the inter-observer reproducibility with different histological criteria used in celiac disease. Clin Gastroenterol Hepatol 2007, 5:838-843.
24. Hayat M., Cairns A., Dixon M.F., et al. Quantitation of intraepithelial lymphocytes in human duodenum: what is normal?. J Clin Pathol 2002, 55:393-395.
25. Howdle P.D., Corazza G.R., Bullen A.W., et al. Gluten sensitivity of small intestinal mucosa in vitro: quantitative assessment of histological changes. Gastroenterology 1981, 80:442-450.
26. Carroccio A., Di Prima L., Pirrone G., et al. Anti-transglutaminase antibody assay of the culture medium of intestinal biopsy specimens can improve the accuracy of celiac disease diagnosis. Clin Chem 2006, 52:1175-1180.
27. Salentijn E., Goryunova S.V., Bas N., et al. Tetraploid and hexaploid wheat varieties reveal large differences in expression of alpha-gliadins from homologous Gli-2 loci. BMC Genom 2009, 10:48. 10.1186/1471-2164r-r10-48.
28. Mitea D.C., Salentjin E., Smulders M.J.M., et al. Diploid wheat accessions differ in toxicity for celiac disease patients. Proceeding of XIII international celiac disease symposium 2009, [abstract book], p. 161.
29. Molberg O., Uhlen A.K., Jensen T., et al. Mapping of gluten T-cell epitopes in the bread wheat ancestors: implications for celiac disease. Gastroenterology 2005, 128:393-401.
30. Bracken S.C., Kilmartin C., Wieser H., et al. Barley and rye prolamins induce an mRNA interferon-c response in coeliac mucosa. Aliment Pharmacol Ther 2006, 23:1307-1314.
31. Kasarda D.D., Qualset C.O., Mecham D.K., et al. A test of toxicity of bread made from wheat lacking-gliadins coded for by the 6A chromosome. Perspectives in coeliac disease 1978, 55-61. MTP Press, Lancaster. B. McNicholl, C.F. McCarthy, P.F. Fottrell (Eds.).
32. Maiuri L., Troncone R., Mayer M., et al. In vitro activities of A-gliadin-related synthetic peptides: damaging effect on the atrophic celiac mucosa and activation of mucosal immune response in the treated coeliac mucosa. Scand J Gastroenterol 1996, 31:247-253.
33. Sturgess R., Day P., Hellis H.J. Wheat peptide challenge in celiac disease. Lancet 1994, 343:758-761.
34. Maiuri L., Ciacci C., Ricciardelli I., et al. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 2003, 362:30-37.
35. Barone M.V., Gimigliano A., Castoria G., et al. Growth factor-like activity of gliadin, an alimentary protein: implications for coeliac disease. Gut 2007, 56:480-488.
36. Clemente M.G., De Virgilis S., Kang J.S., et al. Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier functions. Gut 2003, 52:218-223.
37. Nielsen E.M., Jahnsen F.L., Lundin K.E., et al. Gluten induces an intestinal cytokine response strongly dominated by interferon gamma in patients with celiac disease. Gastroenterology 1998, 15:551-563.
38. Forsberg G., Hernell O.L., Melgar S., et al. Paradoxical coexpression of proinflammatory and downregulatory cytokines in intestinal T cells in childhood celiac disease. Gastroenterology 2002, 123:667-678.
39. Salvati V., Mazzarella G., Gianfrani C., et al. Recombinant human IL-10 suppresses gliadin-dependent T-cell activation in ex vivo cultured celiac intestinal mucosa. Gut 2005, 54:46-53.
40. Gianfrani C., Levings M.K., Sartirana C., et al. Gliadin-specific type I regulatory T cells from the intestinal mucosa of treated celiac patients inhibit pathogenic T cells. J Immunol 2006, 177:4178-4186.
41. Shan L., Molberg O., Parrot I., et al. Structural basis for gluten intolerance in celiac sprue. Science 2002, 297:2275-2279.
42. Picarelli A., Maiuri L., Frate A., et al. Production of anti-endomysial antibodies after in vitro gliadin challenge of small intestine biopsy samples from patients with celiac disease. Lancet 1996, 348:1065-1067.
43. Picarelli A., Di Tola M., Sabbatella L., et al. Usefulness of the organ culture system in the in vitro diagnosis of coeliac disease: a multicentre study. Scand J Gastroenterol 2006, 41:186-190.
44. Carroccio A., Iacono G., D'Amico D., et al. Production of anti-endomysial antibodies in cultured duodenal mucosa: usefulness in coeliac disease diagnosis. Scand J Gastroenterol 2002, 37:32-38.
45. Stenman S.M., Lindfors K., Korponay-Szabo I.R. Secretion of celiac disease autoantibodies after in vitro gliadin challenge is dependent on small-bowel mucosal transglutaminase 2-specific IgA deposits. BMC Immunol 2008, 9:6.
46. Troncone R., Ivarsson A., Szajewska H., et al. Review article: future research on coeliac disease-a position report from the European multi-stakeholder platform on coeliac disease (CDEUSSA). Aliment Pharmacol Ther 2008 Jun 1, 27:1030-1043.
47. Rizzello C.G., De Angelis M., Di Cagno R., et al. Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease. Appl Environ Microbiol 2007, 73:4499-4507.
48. Di Cagno R., Rizzello C.G., De Angelis M., et al. Use of selected sourdough strains of Lactobacillus for removing gluten and enhancing the nutritional properties of gluten-free bread. J Food Prot 2008, 71:1491-1495.
49. Paterson B.M., Lammers K.M., Arrieta M.C., et al. The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study. Aliment Pharmacol Ther 2007, 26:757-766.
50. Anderson R.P. Coeliac disease: current approach and future prospects. Intern Med J 2008, 38:790-799.